While most side effects from GLP-1 medications are gastrointestinal, rapid weight loss and changes in bile composition can sometimes lead to gallbladder issues such as pain, nausea after fatty meals, or gallstone formation
Research interest in Epithalon stems from efforts to replicate, in a defined peptide form, mechanisms observed with the parent extract
Researchers debate how much of that loss is a normal, expected adjustment to carrying less body weight versus a change worth actively preventing
These promoter regions act like dimmer switches for gene expression, and by binding here, Epitalon appears to gently dial up telomerase gene transcription without altering the DNA itself
Table 2 Characteristics of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-associated psychiatric disorders: adverse event (AE) reports sourced from the FDA Adverse Event Reporting System (FAERS) database (Q1 2004Q1 2023)